Efficacy and Safety of Combination Antiplatelet Therapies in Patients With Symptomatic Intracranial Atherosclerotic Stenosis Background and purpose: An optimal strategy for management of symptomatic intracranial atherosclerotic stenosis (ICAS) has not yet been established.
<h3>What is
Antiplatelet Therapies?</h3>
A class of medications known as antiplatelets prevents blood cells, or platelets, from clumping together and producing a blood clot.
Platelets are transported to the site of an injury whenever it occurs in your body, where they cluster together to create a blood clot. Your body's bleeding is stopped by this. This is advantageous if you have a wound or cut. But occasionally, in a blood artery that is damaged, swollen (inflamed), or that has plaque buildup, platelets will congregate (atherosclerosis). When this occurs, the platelets may lead to the formation of a blood clot inside the vessel. Placing stents, artificial heart valves, and other devices inside the heart might also result in blood clots from platelets.
To learn more about Antiplatelet Therapies from the given link:
brainly.com/question/28086164
#SPJ4
